Efficacy of Minoxidil Combined With Photobiomodulation for the Treatment of Male Androgenetic Alopecia. A Double‐Blind Half‐Head Controlled Trial
- 16 May 2021
- journal article
- research article
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 53 (9) , 1201-1207
Abstract
Background: Androgenetic alopecia (AGA) is a hair loss disorder that frequently affects the male population. Conventional treatment modalities are limited to minoxidil, 5α reductase inhibitors, and hair transplantation procedures. The efficacy of low‐level laser therapy (LLLT), also known as photobiomodulation, in the treatment of AGA has been reported, yet little is known about the outcomes of combining photobiomodulation with other conventional therapies.Objective: To evaluate hair growth improvement in males with AGA, during the administration of minoxidil with and without photobiomodulation, using a half‐head model.Study Design/Materials and Methods: Twenty‐one men with AGA agreed to undergo 12 minutes of low‐level laser irradiation (using a modified Capellux®), followed by topical minoxidil application (1 ml of 5% solution), to the affected scalp two times per day for 6 months. The photobiomodulation devices were modified such that the left half emitted light, and the right half did not. Efficacy was assessed by blinded analyses of clinical photos and automated phototrichograms (Trichoscan®) taken before treatment and after 3 and 6 months of therapy.Results: None of the study participants experienced any adverse events. All patients showed improvements in hair coverage on both sides of the scalp at 3 and 6 months. On the side with combined treatments, the number of total hairs was significantly increased after 3 (P < 0.001) and 6 months (P = 0.001). A similar increase was also observed on the minoxidil‐only side, at both 3 (P < 0.001) and 6 months (P < 0.001). No statistically significant differences were detected between sides (P > 0.05).Conclusion: Additional improvement was not observed with the association of photobiomodulation to topical minoxidil in male AGA. Differences from previous studies that might have influenced our result include non‐collimated light source, higher dosimetry, and a cohort with darker skin phototype and more severe alopecia. Lasers Surg. Med. 2021. © 2021 Wiley Periodicals LLCKeywords
This publication has 23 references indexed in Scilit:
- Efficacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-controlled, Double-blind StudyAmerican Journal of Clinical Dermatology, 2014
- Quality of Life Assessment in Male Patients with Androgenetic Alopecia: Result of a Prospective, Multicenter StudyAnnals of Dermatology, 2012
- The Nuts and Bolts of Low-level Laser (Light) TherapyAnnals of Biomedical Engineering, 2011
- Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200-rich and CD34-positive hair follicle progenitor cellsJournal of Clinical Investigation, 2011
- Efficacy and Safety of Finasteride Therapy for Androgenetic AlopeciaArchives of Dermatology, 2010
- Biphasic Dose Response in Low Level Light TherapyDose-Response, 2009
- The current role of laser/light sources in the treatment of male and female pattern hair lossJournal of Cosmetic and Laser Therapy, 2007
- Prevalence of Male and Female Pattern Hair Loss in MaryboroughJournal of Investigative Dermatology Symposium Proceedings, 2005
- Topical minoxidil in early male pattern baldnessJournal of the American Academy of Dermatology, 1985
- PATTERNED LOSS OF HAIR IN MAN: TYPES AND INCIDENCEAnnals of the New York Academy of Sciences, 1951